Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-023907
Filing Date
2026-07-21
Accepted
2026-07-21 06:01:01
Documents
10
Period of Report
2026-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K athe20260721_6k.htm 6-K 10820
2 EXHIBIT 99.1 ex_990685.htm EX-99.1 5929
3 alterity_page01.jpg GRAPHIC 68076
4 alterity_page02.jpg GRAPHIC 56484
5 alterity_page03.jpg GRAPHIC 50149
6 alterity_page04.jpg GRAPHIC 108325
7 alterity_page05.jpg GRAPHIC 54732
8 alterity_page06.jpg GRAPHIC 35667
9 alterity_page07.jpg GRAPHIC 119638
10 alterity_page08.jpg GRAPHIC 45597
  Complete submission text file 0001437749-26-023907.txt   759017
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 261188090
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)